Phase Inpatient Withdrawal Programme for Long-Term Opioid Use in Non-Cancer Pain,” published in the March 2025 issue of ...

The global non-opioid pain patches market is experiencing substantial growth, driven by increasing demand for safer and more effective pain management solutions. In 2022, the market surpassed USD 3.3 ...

The study, which was published in the journal Pharmacological Reports, analyzed the impact of four terpenes that are found in ...

In this systematic review, evidence for the efficacy of acute pain interventions on individuals with opioid use disorder was ...

Each year, millions of people in America are prescribed a medicine for acute pain.Now, for the first time in over 20 years, ...

The FDA approves a new non-opioid pain pill, Journavx, to treat acute pain in adults. It's a first-generation non-addictive ...

Increasingly, these pleas are not just about pain management but about finding ways to end their lives, as years of forced reductions or complete discontinuation of the opioid painkillers ...

A separate review by theCommission on Human Medicines (CHM) concluded that the risks of using prolonged-release opioids for short-term postoperative pain exceeded the benefits. The CHM recommended ...

Congress and the Florida Legislature must eliminate cost disparities between opioid and non-opioid options.

The round, which included more than a dozen investment firms, should give the startup enough cash to get late-stage data for ...